学術情報 -AJRCCM(ブルージャーナル) KYORIN SELECTION-

2018年09月 -PART 02-

慢性喘息モデルにおける吸入インターロイキン13抗体フラグメントの有効性

Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma Am J Respir Crit Care Med 2018; 198(5): 610-619

プライマリケア医師は睡眠時無呼吸患者の総合的管理が可能である:非劣性無作為化比較試験

Primary Care Physicians Can Comprehensively Manage Patients with Sleep Apnea A Noninferiority Randomized Controlled Trial Am J Respir Crit Care Med 2018; 198(5): 648-656

肺結核に対する高用量リファンピシンの有効性及び安全性:無作為化比較試験

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis A Randomized Controlled Trial Am J Respir Crit Care Med 2018; 198(5): 657-666

2018年09月 -PART 01-

黄色ブドウ球菌は上皮細胞由来サイトカインを介して粘膜に2型免疫応答を誘導する

Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell-derived Cytokines Am J Respir Crit Care Med 2018; 198(4): 452-463

慢性閉塞性肺疾患(COPD)の一般診療集団におけるCOPD増悪の自然経過

Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice‒based Population with Chronic Obstructive Pulmonary Disease Am J Respir Crit Care Med 2018; 198(4): 464-471

健康マウスの肺微生物叢は変動が大きく、環境に応じてクラスターを形成し、ベースライン肺自然免疫の変動を反映する

The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity Am J Respir Crit Care Med 2018; 198(4): 497-508

Selected articles from AJRCCM. Copyright 2018 by the American Thoracic Society. All rights reserved. The ideas and opinions expressed in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) or other associated publications do not necessarily reflect those of the American Thoracic Society (ATS). The authors, editors or ATS are not responsible for errors or omissions of articles published in print or online from AJRCCM or other associated ATS publications. Although great care has been taken in compiling the content of this publication, neither ATS or their servants are responsible or liable in any way for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising there from. Approved product information should be reviewed before prescribing. The mention of any product, service, or therapy in this publication should not be construed as an endorsement of the products mentioned. It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, method, and duration of administration, or contraindications. Readers are also encouraged to contact the manufacturer with questions about the features or limitations of any products. ATS assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. 

The translation is © 2018 American Thoracic Society. American Thoracic Society or Springer Healthcare takes no responsibility for the accuracy of the translation from the published English original and are not liable for any errors that may occur.